Cargando…
Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation
SUMMARY: Cushing’s syndrome is associated with increased morbidity and mortality. Although surgery is the first-line treatment, drugs can still play a role as an ancillary treatment to be employed while waiting for surgery, after unsuccessful operation or in patients unsuitable for surgery. We were...
Autores principales: | Attanasio, Roberto, Cortesi, Liana, Gianola, Daniela, Vettori, Claudia, Sileo, Fulvio, Trevisan, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404471/ https://www.ncbi.nlm.nih.gov/pubmed/28458898 http://dx.doi.org/10.1530/EDM-16-0140 |
Ejemplares similares
-
Cushing’s disease: Does low-dose pasireotide offer a comparable efficacy and safety to high-dose?
por: Wong, Mimi, et al.
Publicado: (2021) -
Pasireotide therapy in a rare and unusual case of plurihormonal pituitary macroadenoma
por: Rajendran, Rajesh, et al.
Publicado: (2013) -
Pasireotide in an insulin-requiring diabetic acromegalic patient without worsening of hyperglycemia
por: Gordon, Murray B, et al.
Publicado: (2017) -
Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly
por: Amarawardena, W K M G, et al.
Publicado: (2017) -
Effective long-term temozolomide rechallenge in a macroprolactinoma
por: Zampetti, Benedetta, et al.
Publicado: (2018)